IL1A and Peri-Implantitis: The development of easier diagnostic procedures and protocols may allow for better and cheaper diagnostics, especially for mixed IL-1α/IL-1β genotypes, thus allowing for the “tailor made” treatment of peri-implantitis and the early screening and maintenance of high-risk patients.